Search - tctmd.com

Displaying 321 - 340 of 367

Sort: Relevancy | Date

News Industry News

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Daily News

Renal Denervation Shows Promise in Patients Refractory to Stenting

L.A. McKeown

May 02, 2014

News Daily News

Clinical Outcomes of Carotid Stenting Comparable in Radiation-Induced and Atherosclerotic Stenoses

L.A. McKeown

April 11, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

Yael L. Maxwell

January 27, 2014

News Industry News

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

December 16, 2013

News Conference News AHA 2013

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Jason Kahn

November 17, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Daily News

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

September 13, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Daily News

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

July 19, 2013

News Daily News

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

Caitlin E. Cox

July 05, 2013

News Industry News

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

June 04, 2013

News Industry News

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013

News Industry News

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

May 22, 2013

News Daily News

Post-TAVR Hypertension Common, Predicts Better Outcomes

May 03, 2013

Advertisement

Preliminary Results From the St. Jude Medical EnligHTN III Study Demonstrate Renal Denervation Is Safe and Effective

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Renal Denervation Shows Promise in Patients Refractory to Stenting

Clinical Outcomes of Carotid Stenting Comparable in Radiation-Induced and Atherosclerotic Stenoses

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Year in Review: Physicians Highlight the Most Important Interventional News of 2013

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

Post-TAVR Hypertension Common, Predicts Better Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content